ArticleDer Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen2008
[Esophageal carcinoma. Results after esophageal resection].
Article in Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe central element of the multimodal therapy concept for esophageal carcinomas is operative resection. This is a complex visceral surgical intervention that calls for standardized and interdisciplinary perioperative management. Continuous control of results is essential for evaluating therapy concepts.
methodData of patients who had undergone thoracoabdominal resection of an esophageal carcinoma were recorded and evaluated in a prospective single center study within the framework of internal quality control.
resultsIn the time span between 1 January 1997 and 31 December 2005, 193 patients with esophageal carcinoma were treated. Of these, 97 (50.7%) received single-stage abdominothoracal resection without neoadjuvant primary therapy. In 70% of these cases, an advanced tumor stage was present (UICC IIb or higher). R0 resection was achieved in 83 patients (85.5%). The rate of hospital mortality was found to be 6.2% (n=6). In a follow-up examination rate of 95.6%, an overall 5-year survival rate of 25% was found for all resected patients and 30% for those who received curative resection.
conclusionThe long-term results reached by surgery alone are comparable to those published in the current literature but are still not satisfying. A more individual approach to therapy with increased selection of patients for the application of modern neoadjuvant concepts could lead to an improvement in prognosis.
Indexed as
Identifiers
18030434What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.